Recall archive / FDA drug enforcement

Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc. — FDA record D-0789-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Apr 12, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc.
Reason: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Classification: Class II
Recalling firm: Preferred Pharmaceuticals, Inc.
Quantity: 44 Bottles of 90 Tablets 33 Bottles of 30 Tablets
Agency-reported status: Terminated
Source record identifier: D-0789-2022

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	Lot: E1321O, Exp.: 5/31/2023 Lot: E2521H, Exp.: 5/31/2023 Lot: E2621F, Exp.: 5/31/2023

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Nationwide within the U.S to CA, IN and FL.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date: May 4, 2022
Recall initiation date: Apr 12, 2022
Center classification date: Apr 26, 2022
Termination date: Sep 22, 2022

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.